The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Agios; Amgen; Astellas Pharma; BMS Brazil; Macrogenics; Orsenix; Xencor
Consulting or Advisory Role - Agios; Amgen; Astellas Pharma; BMS Brazil; Macrogenics; Orsenix; Xencor
Research Funding - Abbvie; Amgen; Astellas Pharma; BMS Brazil; Macrogenics; Orsenix; Xencor
CLI24-001: First-in-human study of SEL24/MEN1703, an oral dual PIM/FLT3 kinase inhibitor, in patients with acute myeloid leukemia.
 
Farhad Ravandi
No Relationships to Disclose
 
Stephen Anthony Strickland
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Jazz Pharmaceuticals; Kite, a Gilead company; Novartis; Pfizer; Tolero Pharmaceuticals
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Celator/Jazz (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Karyopharm Therapeutics (Inst); Menarini (Inst); Novartis (Inst); Sunesis Pharmaceuticals (Inst)
 
Scott R. Solomon
No Relationships to Disclose
 
Aziz Nazha
Honoraria - Karyopharm Therapeutics; Tolero Pharmaceuticals
Consulting or Advisory Role - MEI Pharma
Speakers' Bureau - Incyte; Novartis
Research Funding - Jazz Pharmaceuticals
 
Roland B. Walter
Stock and Other Ownership Interests - Amphivena Therapeutics
Consulting or Advisory Role - Agios; Amphivena Therapeutics; argenx; BiolineRx; BiVictriX; Boehringer Ingelheim; Boston Biomedical; Covagen; Daiichi Sankyo; Emergent Biosolutions; Jazz Pharmaceuticals; Kite, a Gilead company; Pfizer; Race Oncology; Tolero Pharmaceuticals
Research Funding - Abbvie; ADC Therapeutics; Agios; Amgen; Aptevo Therapeutics; Arog; BiolineRx; Celator; Covagen AG; Jazz Pharmaceuticals; Pfizer; Pharmacyclics; Seagen; Selvita; Stemline Therapeutics
 
Ilaria Valimberti
Employment - Menarini
 
Alessia Tagliavini
Employment - Menarini
 
Caterina Fiesoli
Employment - Menarini
 
Monica Binaschi
Employment - Menarini
 
Krzysztof Brzozka
Employment - Selvita
Leadership - Selvita
Stock and Other Ownership Interests - Nodthera; Selvita
Honoraria - Selvita
Patents, Royalties, Other Intellectual Property - Selvita
Travel, Accommodations, Expenses - Nodthera
 
Simone Baldini
Employment - Menarini
 
Steffen Heeger
Employment - Selvita
Leadership - Selvita
Stock and Other Ownership Interests - MorphoSys
Honoraria - Selvita
Consulting or Advisory Role - Merck KGaA
Patents, Royalties, Other Intellectual Property - MorphoSys
 
Andrea Ugo Pellacani
Employment - Menarini
Leadership - Menarini
Stock and Other Ownership Interests - Amgen; Amgen (I)